0001227025-21-000198.txt : 20210803 0001227025-21-000198.hdr.sgml : 20210803 20210803160904 ACCESSION NUMBER: 0001227025-21-000198 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210803 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210803 DATE AS OF CHANGE: 20210803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOPHOTONICS CORP CENTRAL INDEX KEY: 0001227025 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 943253730 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35061 FILM NUMBER: 211139786 BUSINESS ADDRESS: STREET 1: 3081 ZANKER ROAD CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 4082329200 MAIL ADDRESS: STREET 1: 3081 ZANKER ROAD CITY: SAN JOSE STATE: CA ZIP: 95134 8-K 1 nptn-20210803.htm 8-K nptn-20210803
false000122702500012270252021-08-032021-08-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 3, 2021
NEOPHOTONICS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-35061 94-3253730
(State of incorporation) (Commission File No.) (IRS Employer Identification No.)
NeoPhotonics Corporation
3081 Zanker Road
San Jose, California 95134
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (408) 232-9200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:Trading symbol(s):Name of each exchange on which registered:
Common Stock, $0.0025 par valueNPTNNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




ITEM 2.02          RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On August 3, 2021, the Company issued a press release regarding the Company’s financial results for the second quarter ended June 30, 2021. A copy of the Company’s press release is furnished and attached as Exhibit 99.1 to this Form 8-K.
The information contained in this Item 2.02, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and shall not be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01          FINANCIAL STATEMENTS AND EXHIBITS.
(d)    Exhibits.
Exhibit NumberDescription
  
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 3, 2021NEOPHOTONICS CORPORATION
   
 By:/S/  ELIZABETH EBY
  Elizabeth Eby
  
Senior Vice President, Finance and
Chief Financial Officer
  
(Principal Financial and
Accounting Officer)


EX-99.1 2 exhibit991_832021.htm EX-99.1 Document

nptnq22019logoa01.jpg

NeoPhotonics Reports Second Quarter 2021 Financial Results

Product Revenue for 400G and above applications grew 100% year-over-year
400ZR modules are in General Availability


SAN JOSE, Calif. — August 3, 2021 - NeoPhotonics Corporation (NYSE: NPTN), a leading developer of silicon photonics and advanced hybrid photonic integrated circuit-based lasers, modules and subsystems for bandwidth-intensive, high speed communications networks, today announced financial results for its second quarter of 2021.

“Building on our strong performance in the second quarter, we see accelerating growth in the back half of the year, driven by the initial ramp of 400ZR and related products adding to our 400G+ suite,” said Tim Jenks, Chairman and CEO of NeoPhotonics. “We are ramping our modules and component level products, including our Nano Tunable Laser, putting us in a good position to return to profitability,” concluded Mr. Jenks.

Second Quarter 2021 Summary

Revenue was $65.0 million, up 7% quarter-over-quarter and down 37% year-over-year
Gross margin was 15.2%, down from 21.9% in the prior quarter
Non-GAAP gross margin was 21.7%, down from 22.4% in the prior quarter
Net loss per share was $0.34, compared to net loss of $0.21 per share in the prior quarter
Non-GAAP net loss per share was $0.22, compared to Non-GAAP net loss of $0.15 per share in the prior quarter
Adjusted EBITDA was negative $5.4 million, down from a negative $0.7 million in the prior quarter

Non-GAAP results in the second quarter of 2021 exclude a $3.3 million end-of-life related inventory write-down, $2.3 million of stock-based compensation and $0.4 million of accelerated depreciation, amortization and other charges. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release.

As of June 30, 2021, cash and cash equivalents, short-term investments and restricted cash totaled $95 million.

Outlook for the Quarter Ending September 30, 2021
GAAPNon-GAAP
Revenue$76 to $84 million
Gross Margin24% to 29%25% to 30%
Operating Expenses$26 to $27 million$23 to $24 million
Earnings per share($0.20) to ($0.10)($0.10) to $0.00

The non-GAAP outlook for the third quarter of 2021 excludes the expected impact of stock-based compensation expense of approximately $3.3 million, of which $0.7 million is estimated for cost of goods sold, accelerated depreciation and amortization of $0.5 million.

1



Non-GAAP and Adjusted EBITDA Measures vs. GAAP Financial Measures

The Company’s non-GAAP and Adjusted EBITDA measures exclude certain GAAP financial measures. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release. These non-GAAP financial measures differ from GAAP measures with the same captions and may differ from non-GAAP financial measures with the same or similar captions that are used by other companies. As such, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.

The Company uses these non-GAAP financial measures to analyze its operating performance and future prospects, develop internal budgets and financial goals, and to facilitate period-to-period comparisons. NeoPhotonics believes that these non-GAAP financial measures reflect an additional way of viewing aspects of its operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.

Conference Call

The Company will host a conference call today, Tuesday, August 3, 2021 at 4:30 p.m. EDT (1:30 p.m. PDT). The call will be available, live, to interested partied by dialing 800-437-2398 or +1 313-209-6317. The Conference ID number is 5316525. Please dial into the conference call 5-10 minutes prior to the scheduled start time.

A live webcast will be available in the Investor Relations section of NeoPhotonics’ website at: http://ir.neophotonics.com/phoenix.zhtml?c=236218&p=irol-calendar.

A replay of the webcast will be available in the Investor Relations section of the Company’s website approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.

About NeoPhotonics

NeoPhotonics is a leading developer and manufacturer of lasers and optoelectronic solutions that transmit, receive and switch high-speed digital optical signals for Cloud and hyper-scale data center internet content provider and telecom networks. The Company’s products enable cost-effective, high-speed over distance data transmission and efficient allocation of bandwidth in optical networks. NeoPhotonics maintains headquarters in San Jose, California and ISO 9001:2015 certified engineering and manufacturing facilities in Silicon Valley (USA), Japan and China. For additional information visit www.neophotonics.com.



Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

This press release includes statements that qualify as forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements about the following topics: future financial results, demand for the Company’s high-speed products, and the Company’s market position. Forward-looking statements are subject to certain risks and uncertainties that could cause the actual results to differ materially. Those risks and uncertainties include, but are not limited to, such factors as: the Company’s reliance on a small number of customers for a substantial portion of its revenues; market growth in key countries; possible reduction in or volatility of customer orders or delays in shipments of products to customers; possible disruptions in the supply chain or in
2



demand for the Company’s products timing of customer drawdowns of vendor-managed inventory; potential governmental trade actions; ; the ability of the Company's vendors and subcontractors to supply or manufacture the Company's products in a timely manner; ability of the Company to meet customer demand; volatility in utilization of manufacturing operations and manufacturing costs; reductions in the Company’s rate of new design wins, and/or the rate at which design wins go into production, and the rate of customer acceptance of new product introductions; potential pricing pressure that may arise from changing conditions in the industry or negotiating leverage of buyers; the discontinuance or end of life of products; changes in demand for the Company's products; the impact of competitive products and pricing and alternative technological advances; the accuracy of estimates used to prepare the Company's financial statements and forecasts; the timely and successful development and market acceptance of new products and upgrades to existing products; the difficulty of predicting future cash needs; the nature of other investment opportunities available to the Company from time to time; the Company’s operating cash flow; changes in economic and industry projections; and a decline in general conditions in the telecommunications equipment industry, the cloud and datacenter industry, or the world economy generally. For further discussion of these risks and uncertainties, please refer to the documents the Company files with the SEC from time to time, including the Company's Annual Reports on Form 10-K for the year ended December 31, 2020. All forward-looking statements are made as of the date of this press release, and the Company disclaims any duty to update such statements.


©2021 NeoPhotonics Corporation. All rights reserved. NeoPhotonics and the red dot logo are trademarks of NeoPhotonics Corporation. All other marks are the property of their respective owners.
3



NeoPhotonics Corporation
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands)

 As of
 Jun. 30, 2021Dec. 31, 2020
 
ASSETS  
Current assets:  
Cash and cash equivalents
$66,836 $95,117 
Short-term investments
27,672 27,669 
Restricted cash
495 489 
Accounts receivable, net
47,763 45,232 
Inventories
44,341 46,901 
Prepaid expenses and other current assets
14,307 20,173 
Total current assets
201,414 235,581 
Property, plant and equipment, net59,942 66,765 
Operating lease right-of-use assets14,452 13,823 
Purchased intangible assets, net1,139 1,468 
Goodwill1,115 1,115 
Other long-term assets5,193 4,912 
Total assets
$283,255 $323,664 
LIABILITIES AND STOCKHOLDERS’ EQUITY  
Current liabilities:  
Accounts payable
$46,648 $43,539 
Current portion of long-term debt
3,033 3,232 
Accrued and other current liabilities
25,461 42,053 
Total current liabilities
75,142 88,824 
Long-term debt, net of current portion27,488 30,327 
Operating lease liabilities, noncurrent14,787 14,522 
Other noncurrent liabilities8,446 9,584 
Total liabilities
125,863 143,257 
   
Stockholders’ equity:  
Common stock
130 126 
Additional paid-in capital
602,877 597,460 
Accumulated other comprehensive income1,423 1,735 
Accumulated deficit
(447,038)(418,914)
Total stockholders’ equity
157,392 180,407 
Total liabilities and stockholders’ equity
$283,255 $323,664 

4



NeoPhotonics Corporation
Condensed Consolidated Statements of Operations (Unaudited)
(In thousands, except percentages and per share data)

 Three Months EndedSix Months Ended
 Jun. 30, 2021Mar. 31, 2021Jun. 30, 2020Jun. 30, 2021Jun. 30, 2020
Revenue$65,010 $60,926 $103,171 $125,935 $200,572 
Cost of goods sold (1)55,135 47,587 69,669 102,721 137,344 
Gross profit9,875 13,339 33,502 23,214 63,228 
Gross margin
15.2 %21.9 %32.5 %18.4 %31.5 %
Operating expenses:     
Research and development (1)
15,410 13,098 13,689 28,508 25,573 
Sales and marketing (1)
3,362 3,865 4,279 7,227 7,938 
General and administrative (1)
7,398 7,294 8,803 14,692 15,592 
Acquisition and asset sale related costs (recoveries)
(36)163 120 127 132 
Restructuring charges
22 — — 22 — 
Total operating expenses
26,156 24,420 26,891 50,576 49,235 
Income (loss) from operations(16,281)(11,081)6,611 (27,362)13,993 
Interest income
140 105 22 245 120 
Interest expense
(220)(227)(301)(447)(679)
Other income (expense), net
(880)1,143 (195)263 1,003 
Total interest and other income (expense), net
(960)1,021 (474)61 444 
Income (loss) before income taxes(17,241)(10,060)6,137 (27,301)14,437 
Income tax provision(191)(632)(412)(823)(2,405)
Net income (loss)$(17,432)$(10,692)$5,725 $(28,124)$12,032 
Basic net income (loss) per share$(0.34)$(0.21)$0.12 $(0.55)$0.25 
Diluted net income (loss) per share$(0.34)$(0.21)$0.11 $(0.55)$0.24 
Weighted average shares used to compute basic net income (loss) per share
51,634 50,717 49,077 51,178 48,846 
Weighted average shares used to compute diluted net income (loss) per share
51,634 50,717 51,661 51,178 51,124 
(1) Includes stock-based compensation expense as follows for the periods presented:
     
Cost of goods sold
$572 $548 $621 $1,120 $1,158 
Research and development
744 862 999 1,606 1,757 
Sales and marketing
261 554 738 815 1,268 
General and administrative
763 1,313 1,429 2,076 2,122 
Total stock-based compensation expense
$2,340 $3,277 $3,787 $5,617 $6,305 

5



NeoPhotonics Corporation
Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited)
(In thousands, except percentages and per share data)

 Three Months EndedSix Months Ended
 Jun. 30, 2021Mar. 31, 2021Jun. 30, 2020Jun. 30, 2021Jun. 30, 2020
NON-GAAP GROSS PROFIT:    
GAAP gross profit$9,875 $13,339 $33,502 $23,214 $63,228 
Stock-based compensation expense
572 548 621 1,120 1,158 
Amortization of purchased intangible assets
153 185 184 338 368 
Depreciation of acquisition-related fixed asset step-up(6)(8)(3)(20)
End-of-life related inventory write-down (sell-through)3,257 (577)— 2,680 — 
Accelerated depreciation
157 174 — 331 — 
Restructuring charges
113 — — 113 — 
Non-GAAP gross profit$14,130 $13,663 $34,299 $27,793 $64,734 
Non-GAAP gross margin as a % of revenue21.7 %22.4 %33.2 %22.1 %32.3 %
NON-GAAP TOTAL OPERATING EXPENSES:
    
GAAP total operating expenses$26,156 $24,420 $26,891 $50,576 $49,235 
Stock-based compensation expense
(1,768)(2,729)(3,166)(4,497)(5,147)
Depreciation of acquisition-related fixed asset step-up(21)(25)(28)(46)(57)
Acquisition and asset sale related costs (recoveries)36 (163)(120)(127)(132)
Restructuring charges
(22)— — (22)— 
Non-GAAP total operating expenses$24,381 $21,503 $23,577 $45,884 $43,899 
Non-GAAP total operating expenses as a % of revenue
37.5 %35.3 %22.9 %36.4 %21.9 %
NON-GAAP OPERATING INCOME (LOSS):    
GAAP income (loss) from operations$(16,281)$(11,081)$6,661 $(27,362)$13,993 
Stock-based compensation expense
2,340 3,277 3,787 5,617 6,305 
Amortization of purchased intangible assets
153 185 184 338 368 
Depreciation of acquisition-related fixed asset step-up24 19 20 43 37 
Acquisition and asset sale related costs (recoveries)(36)163 120 127 132 
End-of-life related inventory write-down (sell-through)3,257 (577)— 2,680 — 
Accelerated depreciation
157 174 — 331 — 
Restructuring charges
135 — — 135 — 
Non-GAAP income (loss) from operations$(10,251)$(7,840)$10,772 $(18,091)$20,835 
Non-GAAP operating margin as a % of revenue(15.8)%(12.9)%10.4 %(14.4)%10.4 %











6



NeoPhotonics Corporation
Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Continued)
(In thousands, except percentages and per share data)
 Three Months EndedSix Months Ended
 Jun. 30, 2021Mar. 31, 2021Jun. 30, 2020Jun. 30, 2021Jun. 30, 2020
NON-GAAP NET INCOME (LOSS):     
GAAP net income (loss)$(17,433)$(10,692)$5,725 $(28,124)$12,032 
Stock-based compensation expense
2,340 3,277 3,787 5,617 6,305 
Amortization of purchased intangible assets
153 185 184 338 368 
Depreciation of acquisition-related fixed asset step-up24 19 20 43 37 
Acquisition and asset sale related costs (recoveries)(36)163 120 127 132 
End-of-life related inventory write-down (sell-through)3,257 (577)— 2,680 — 
Accelerated depreciation
157 174 — 331 — 
Restructuring charges
135 — — 135 — 
Income tax effect of Non-GAAP adjustments
(17)(2)(1,160)(19)(1,134)
Non-GAAP net income (loss)$(11,420)$(7,453)$8,676 $(18,872)$17,740 
Non-GAAP net income (loss) as a % of revenue(17.6)%(12.2)%8.4 %(15.0)%8.8 %
ADJUSTED EBITDA:     
GAAP net income (loss)$(17,433)$(10,692)$5,725 $(28,124)$12,032 
Stock-based compensation expense
2,340 3,277 3,787 5,617 6,305 
Amortization of purchased intangible assets
153 185 184 338 368 
Depreciation of acquisition-related fixed asset step-up24 19 20 43 37 
Acquisition and asset sale related costs (recoveries)(36)163 120 127 132 
End-of-life related inventory write-down (sell-through)3,257 (577)— 2,680 — 
Accelerated depreciation
157 174 — 331 — 
Restructuring charges
135 — — 135 — 
Interest expense, net
80 122 279 202 559 
Income tax provision191 632 412 823 2,405 
Depreciation expense
5,771 6,003 6,414 11,774 12,887 
Adjusted EBITDA$(5,361)$(694)$16,941 $(6,054)$34,725 
Adjusted EBITDA as a % of revenue(8.2)%(1.1)%16.4 %(4.8)%17.3 %
BASIC AND DILUTED NET INCOME (LOSS) PER SHARE:
     
GAAP basic net income (loss) per share$(0.34)$(0.21)$0.12 $(0.55)$0.25 
GAAP diluted net income (loss) per share$(0.34)$(0.21)$0.11 $(0.55)$0.24 
Non-GAAP basic net income (loss) per share$(0.22)$(0.15)$0.18 $(0.37)$0.36 
Non-GAAP diluted net income (loss) per share$(0.22)$(0.15)$0.16 $(0.37)$0.33 
SHARES USED TO COMPUTE GAAP AND NON-GAAP BASIC NET INCOME (LOSS) PER SHARE
51,634 50,717 49,077 51,178 48,846 
SHARES USED TO COMPUTE GAAP DILUTED NET INCOME (LOSS) PER SHARE51,634 50,717 51,661 51,178 51,124 
SHARES USED TO COMPUTE NON-GAAP DILUTED NET INCOME (LOSS) PER SHARE51,634 50,717 54,303 51,178 53,338 
7



Contacts

NeoPhotonics Corporation
Beth Eby, Chief Financial Officer
+1-408-895-6086
ir@neophotonics.com

Sapphire Investor Relations, LLC
Erica Mannion, Investor Relations
+1-617-542-6180
ir@neophotonics.com
8

EX-101.SCH 3 nptn-20210803.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 nptn-20210803_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 nptn-20210803_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 nptnq22019logoa01.jpg begin 644 nptnq22019logoa01.jpg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end XML 7 nptn-20210803_htm.xml IDEA: XBRL DOCUMENT 0001227025 2021-08-03 2021-08-03 false 0001227025 8-K 2021-08-03 NEOPHOTONICS CORP DE 001-35061 94-3253730 3081 Zanker Road San Jose CA 95134 408 232-9200 false false false false Common Stock, $0.0025 par value NPTN NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page
Aug. 03, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 03, 2021
Entity Registrant Name NEOPHOTONICS CORP
Entity Incorporation, State or Country Code DE
Entity File Number 001-35061
Entity Tax Identification Number 94-3253730
Entity Address, Address Line One 3081 Zanker Road
Entity Address, City or Town San Jose
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95134
City Area Code 408
Local Phone Number 232-9200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0025 par value
Trading Symbol NPTN
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001227025
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.neophotonics.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports nptn-20210803.htm exhibit991_832021.htm nptn-20210803.xsd nptn-20210803_lab.xml nptn-20210803_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nptn-20210803.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "nptn-20210803.htm" ] }, "labelLink": { "local": [ "nptn-20210803_lab.xml" ] }, "presentationLink": { "local": [ "nptn-20210803_pre.xml" ] }, "schema": { "local": [ "nptn-20210803.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nptn", "nsuri": "http://www.neophotonics.com/20210803", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nptn-20210803.htm", "contextRef": "i4a52d2528ed44e12b48f43b99298a252_D20210803-20210803", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.neophotonics.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nptn-20210803.htm", "contextRef": "i4a52d2528ed44e12b48f43b99298a252_D20210803-20210803", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.neophotonics.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001227025-21-000198-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001227025-21-000198-xbrl.zip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�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end